SPRY ARS Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1671858 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.95M 4 sales by 4 insiders
- Filings on record
- 210 since 2021-09-21, latest 2026-09-02 17:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Chakma Justin | Chief Business Off | — | $1.48M |
| Karas Eric | Chief Commercial Off | — | $250.0K |
| Dorsey Brian | COO | — | $190.1K |
| Fitzpatrick Alexander A | CLO | — | $33.5K |
| Shah Pratik | Dir | — | — |
Transactions 170
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-12 20:06 | 2026-06-12 | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +25.0K | 37.2K | +205% | +$37.5K |
| DT | 2026-06-12 20:06 | 2026-06-12 | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $10.00 | -25.0K | 12.2K | -67% | -$250.0K |
| T | 2026-06-12 20:04 | 2026-06-12 | SPRY | Fitzpatrick Alexander A | CLO | S - Sale | $10.00 | -3,355 | 90.9K | -4% | -$33.5K |
| D | 2025-11-14 | 2025-11-13 | SPRY | Dorsey Brian | COO | M - OptEx | $0.64 | +21.8K | 32.6K | +202% | +$14.0K |
| D | 2025-11-14 | 2025-11-13 | SPRY | Dorsey Brian | COO | S - Sale+OE | $8.71 | -21.8K | 10.8K | -67% | -$190.1K |
| MI | 2025-11-14 | 2025-11-12 | SPRY | Shah Pratik | Dir | G - Gift | $0.00 | -350.0K | 4.57M | -7% | $0 |
| DM | 2025-11-14 | 2025-11-12 | SPRY | Chakma Justin | Chief Business Off | S - Sale+OE | $8.87 | -166.4K | 136.4K | -55% | -$1.48M |
| D | 2025-11-14 | 2025-11-12 | SPRY | Chakma Justin | Chief Business Off | M - OptEx | $0.84 | +30.0K | 166.4K | +22% | +$25.2K |
| D | 2025-08-22 | 2025-08-21 | SPRY | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +12.5K | 22.5K | +124% | +$18.8K |
| D | 2025-08-22 | 2025-08-21 | SPRY | Scott Kathleen D. | CFO | S - Sale+OE | $15.00 | -12.5K | 10.0K | -55% | -$187.5K |
| I | 2025-08-22 | 2025-08-21 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $14.49 | -50.0K | 1.20M | -4% | -$724.5K |
| MI | 2025-08-21 | 2025-08-19+ | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $14.08 | -50.0K | 1.29M | -4% | -$703.8K |
| D | 2025-07-03 | 2025-07-01 | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +15.0K | 25.3K | +145% | +$22.5K |
| D | 2025-07-03 | 2025-07-01 | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $16.99 | -15.0K | 10.3K | -59% | -$254.8K |
| MI | 2025-07-01 | 2025-06-27 | SPRY | Flynn James E | 10% | S - Sale | $18.46 | -740.1K | 4.89M | -13% | -$13.66M |
| D | 2025-06-20 | 2025-06-18 | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $16.00 | -15.0K | 7,696 | -66% | -$240.0K |
| D | 2025-06-20 | 2025-06-18 | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +15.0K | 22.7K | +195% | +$22.5K |
| D | 2025-05-22 | 2025-05-20 | SPRY | Fitzpatrick Alexander A | CLO | M - OptEx | $5.58 | +100.0K | 192.6K | +108% | +$558.0K |
| D | 2025-05-22 | 2025-05-20 | SPRY | Fitzpatrick Alexander A | CLO | S - Sale+OE | $14.10 | -103.0K | 89.6K | -53% | -$1.45M |
| D | 2025-05-22 | 2025-05-20 | SPRY | SAUNDERS BRENT L | Dir | M - OptEx | $1.01 | +120.0K | 120.0K | New | +$121.2K |
| D | 2025-05-22 | 2025-05-20 | SPRY | SAUNDERS BRENT L | Dir | S - Sale+OE | $14.25 | -120.0K | 0 | -100% | -$1.71M |
| D | 2025-05-22 | 2025-05-20 | SPRY | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +50.0K | 57.4K | +673% | +$75.0K |
| D | 2025-05-22 | 2025-05-20 | SPRY | Scott Kathleen D. | CFO | S - Sale+OE | $14.10 | -50.0K | 7,424 | -87% | -$705.0K |
| DM | 2025-04-08 | 2025-04-07 | SPRY | Shawver Laura | Dir | M - OptEx | $4.85 | +50.0K | 260.3K | +24% | +$242.5K |
| D | 2025-04-08 | 2025-04-07 | SPRY | Shawver Laura | Dir | S - Sale+OE | $12.30 | -50.0K | 210.3K | -19% | -$615.0K |
| D | 2025-03-21 | 2025-03-20 | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +10.0K | 17.7K | +130% | +$15.0K |
| D | 2025-03-21 | 2025-03-20 | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $14.00 | -10.0K | 7,696 | -57% | -$140.0K |
| DM | 2025-03-07 | 2025-03-05+ | SPRY | Shawver Laura | Dir | M - OptEx | $4.85 | +50.0K | 259.9K | +24% | +$242.5K |
| DM | 2025-03-07 | 2025-03-05+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $11.21 | -50.0K | 210.3K | -19% | -$560.4K |
| DM | 2025-02-04 | 2025-02-03 | SPRY | Shawver Laura | Dir | M - OptEx | $4.54 | +50.0K | 219.4K | +30% | +$227.1K |
| D | 2025-02-04 | 2025-02-03 | SPRY | Shawver Laura | Dir | S - Sale+OE | $12.31 | -50.0K | 210.3K | -19% | -$615.5K |
| D | 2025-01-07 | 2025-01-06 | SPRY | Shawver Laura | Dir | M - OptEx | $3.15 | +50.0K | 260.3K | +24% | +$157.5K |
| D | 2025-01-07 | 2025-01-06 | SPRY | Shawver Laura | Dir | S - Sale+OE | $11.10 | -50.0K | 210.3K | -19% | -$555.0K |
| MI | 2024-12-19 | 2024-12-17 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $11.67 | -100.0K | 1.30M | -7% | -$1.17M |
| MI | 2024-12-19 | 2024-12-17 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $11.67 | -100.0K | 1.10M | -8% | -$1.17M |
| DM | 2024-12-13 | 2024-12-12+ | SPRY | Chakma Justin | Chief Business Off | S - Sale+OE | $12.23 | -144.6K | 136.4K | -51% | -$1.77M |
| DM | 2024-12-13 | 2024-12-12+ | SPRY | Chakma Justin | Chief Business Off | M - OptEx | $0.9532 | +144.6K | 253.7K | +133% | +$137.8K |
| DM | 2024-12-13 | 2024-12-11+ | SPRY | Dorsey Brian | COO | M - OptEx | $0.64 | +40.0K | 31.0K | New | +$25.6K |
| DM | 2024-12-13 | 2024-12-11+ | SPRY | Dorsey Brian | COO | S - Sale+OE | $12.35 | -40.0K | 6,024 | -87% | -$494.0K |
| D | 2024-12-12 | 2024-12-10 | SPRY | Chakma Justin | Chief Business Off | M - OptEx | $0.84 | +50.0K | 186.4K | +37% | +$42.0K |
| D | 2024-12-12 | 2024-12-10 | SPRY | Chakma Justin | Chief Business Off | S - Sale+OE | $13.15 | -50.0K | 136.4K | -27% | -$657.5K |
| MI | 2024-12-11 | 2024-12-10 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $13.16 | -100.0K | 1.25M | -7% | -$1.32M |
| MI | 2024-12-11 | 2024-12-10 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $13.16 | -100.0K | 1.15M | -8% | -$1.32M |
| D | 2024-12-09 | 2024-12-06 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | M - OptEx | $8.42 | +11.9K | 4.33M | +0.3% | +$100.0K |
| DMI | 2024-12-09 | 2024-12-06 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | M - OptEx | $4.67 | +25.7K | 3.43M | +0.8% | +$119.9K |
| DM | 2024-12-09 | 2024-12-06 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $4.67 | +25.7K | 3.43M | +0.8% | +$119.9K |
| DI | 2024-12-09 | 2024-12-06 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $8.42 | +11.9K | 4.33M | +0.3% | +$100.0K |
| DM | 2024-12-06 | 2024-12-04+ | SPRY | Chakma Justin | Chief Business Off | M - OptEx | $0.84 | +144.6K | 181.4K | +394% | +$121.5K |
| DM | 2024-12-06 | 2024-12-04+ | SPRY | Chakma Justin | Chief Business Off | S - Sale+OE | $14.11 | -144.6K | 136.4K | -51% | -$2.04M |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Shawver Laura | Dir | M - OptEx | $2.00 | +200.0K | 298.3K | +203% | +$399.0K |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $13.44 | -200.0K | 210.3K | -49% | -$2.69M |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Chakma Justin | Chief Business Off | S - Sale+OE | $13.43 | -90.0K | 136.4K | -40% | -$1.21M |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Chakma Justin | Chief Business Off | M - OptEx | $0.84 | +90.0K | 181.4K | +98% | +$75.6K |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $14.04 | -10.0K | 5,693 | -64% | -$140.4K |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +10.0K | 9,410 | New | +$15.0K |
| M | 2024-11-27 | 2024-11-25+ | SPRY | Chakma Justin | Chief Business Off | S - Sale | $14.12 | -100.0K | 136.4K | -42% | -$1.41M |
| MI | 2024-11-21 | 2024-11-19 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $13.95 | -100.0K | 1.35M | -7% | -$1.40M |
| MI | 2024-11-21 | 2024-11-19 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $13.95 | -100.0K | 1.20M | -8% | -$1.40M |
| MI | 2024-11-14 | 2024-11-12 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $16.85 | -100.0K | 1.25M | -7% | -$1.68M |
| MI | 2024-11-14 | 2024-11-12 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $16.85 | -100.0K | 1.30M | -7% | -$1.68M |
| MI | 2024-11-13 | 2024-11-11+ | SPRY | Deerfield Private Design Fund III, L.P. | 10% | S - Sale | $18.01 | -563.3K | 5.27M | -10% | -$10.14M |
| MI | 2024-10-17 | 2024-10-15 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $14.88 | -100.0K | 1.40M | -7% | -$1.49M |
| MI | 2024-10-17 | 2024-10-15 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $14.88 | -100.0K | 1.40M | -7% | -$1.49M |
| D | 2024-10-17 | 2024-10-16 | SPRY | Scott Kathleen D. | CFO | S - Sale+OE | $16.00 | -12.5K | 4,949 | -72% | -$200.0K |
| D | 2024-10-17 | 2024-10-16 | SPRY | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +12.5K | 17.4K | +253% | +$18.8K |
| MI | 2024-10-10 | 2024-10-08 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $13.83 | -100.0K | 1.35M | -7% | -$1.38M |
| MI | 2024-10-10 | 2024-10-08 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $13.83 | -100.0K | 1.35M | -7% | -$1.38M |
| D | 2024-09-19 | 2024-09-18 | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $14.00 | -10.0K | 5,693 | -64% | -$140.0K |
| D | 2024-09-19 | 2024-09-18 | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +10.0K | 15.7K | +176% | +$15.0K |
| MI | 2024-09-19 | 2024-09-17 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $12.93 | -100.0K | 1.45M | -6% | -$1.29M |
| MI | 2024-09-19 | 2024-09-17 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $12.93 | -100.0K | 1.40M | -7% | -$1.29M |
| MI | 2024-09-12 | 2024-09-10 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $11.50 | -100.0K | 1.40M | -7% | -$1.15M |
| MI | 2024-09-12 | 2024-09-10 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $11.50 | -100.0K | 1.45M | -6% | -$1.15M |
| I | 2024-08-28 | 2024-08-26 | SPRY | ORBIMED CAPITAL LLC | Dir | S - Sale | $13.00 | -83.7K | 0 | -100% | -$1.09M |
| I | 2024-08-28 | 2024-08-26 | SPRY | Thompson Peter A. | Dir | S - Sale | $13.00 | -83.7K | 0 | -100% | -$1.09M |
| MI | 2024-08-23 | 2024-08-21+ | SPRY | Thompson Peter A. | Dir | S - Sale | $13.24 | -868.7K | 83.7K | -91% | -$11.50M |
| MI | 2024-08-23 | 2024-08-21+ | SPRY | ORBIMED CAPITAL LLC | Dir | S - Sale | $13.24 | -868.7K | 544.7K | -61% | -$11.50M |
| D | 2024-08-21 | 2024-08-20 | SPRY | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +12.5K | 25.7K | +95% | +$18.8K |
| D | 2024-08-21 | 2024-08-20 | SPRY | Scott Kathleen D. | CFO | S - Sale+OE | $16.00 | -12.5K | 13.2K | -49% | -$200.0K |
| D | 2024-08-21 | 2024-08-19 | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +10.0K | 15.7K | +176% | +$15.0K |
| D | 2024-08-21 | 2024-08-19 | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $14.00 | -10.0K | 5,693 | -64% | -$140.0K |
| MI | 2024-08-21 | 2024-08-20 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $15.03 | -100.0K | 1.50M | -6% | -$1.50M |
| MI | 2024-08-21 | 2024-08-20 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $15.03 | -100.0K | 1.50M | -6% | -$1.50M |
| D | 2024-08-21 | 2024-08-20 | SPRY | Dorsey Brian | COO | M - OptEx | $0.64 | +50.0K | 56.0K | +830% | +$32.0K |
| D | 2024-08-21 | 2024-08-20 | SPRY | Dorsey Brian | COO | S - Sale+OE | $15.00 | -50.0K | 6,024 | -89% | -$750.0K |
| D | 2024-08-15 | 2024-08-13 | SPRY | Dorsey Brian | COO | S - Sale+OE | $13.00 | -30.0K | 6,024 | -83% | -$390.0K |
| D | 2024-08-15 | 2024-08-13 | SPRY | Dorsey Brian | COO | M - OptEx | $0.64 | +30.0K | 36.0K | +498% | +$19.2K |
| MI | 2024-08-15 | 2024-08-13 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $12.48 | -100.0K | 1.48M | -6% | -$1.25M |
| MI | 2024-08-15 | 2024-08-13 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $12.48 | -100.0K | 1.45M | -6% | -$1.25M |
| MI | 2024-07-18 | 2024-07-16 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $11.40 | -100.0K | 1.60M | -6% | -$1.14M |
| MI | 2024-07-18 | 2024-07-16 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $11.40 | -100.0K | 1.60M | -6% | -$1.14M |
| MI | 2024-07-11 | 2024-07-09 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.62 | -100.0K | 1.65M | -6% | -$962.0K |
| MI | 2024-07-11 | 2024-07-09 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.62 | -100.0K | 1.50M | -6% | -$962.0K |
| MI | 2024-06-17 | 2024-06-13 | SPRY | Shah Pratik | Dir | G - Gift | $0.00 | -1.33M | 1.13M | -54% | $0 |
| MI | 2024-06-13 | 2024-06-11+ | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.14 | -100.0K | 1.59M | -6% | -$913.9K |
| MI | 2024-06-13 | 2024-06-11+ | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.14 | -100.0K | 1.59M | -6% | -$913.9K |
| I | 2024-06-07 | 2024-06-07 | SPRY | Shah Pratik | Dir, 10% | G - Gift | $0.00 | -1.33M | 4.82M | -22% | $0 |
| AI | 2024-06-07 | 2024-06-04 | SPRY | Pratik Shah Living Trust dated June 15, 2011 | 10% | J - Other | — | -2.67M | 7.49M | -26% | — |
| I | 2024-06-06 | 2024-06-04 | SPRY | Shah Pratik | Dir, 10% | J - Other | — | -2.67M | 7.49M | -26% | — |
| MI | 2024-06-06 | 2024-06-04 | SPRY | Shah Pratik | Dir, 10% | G - Gift | $0.00 | 0 | 6.16M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations